PREFer https://www.nct-dresden.de/en/trials/910-000000084 https://www.nct-dresden.de/@@site-logo/logo-nct.svg PREFer Category Hematological neoplasms Subcategory Hodgkin-Lymphome Trial Type First-Line-Therapy (Metastatic Disease/Hematology) Tumormarkers Description for experts Phase II trial of anti-PD-1 antibody treatment and radiotherapy in early-stage favorable classic Hodgkin lymphoma Description for laymen Phase II trial of anti-PD-1 antibody treatment and radiotherapy in early-stage favorable classic Hodgkin lymphoma
